DK0481058T3 - Humant, lymfatisk væv i en immunokompromitteret vært - Google Patents
Humant, lymfatisk væv i en immunokompromitteret værtInfo
- Publication number
- DK0481058T3 DK0481058T3 DK91909374.0T DK91909374T DK0481058T3 DK 0481058 T3 DK0481058 T3 DK 0481058T3 DK 91909374 T DK91909374 T DK 91909374T DK 0481058 T3 DK0481058 T3 DK 0481058T3
- Authority
- DK
- Denmark
- Prior art keywords
- immunocompromised host
- human
- lymphatic tissue
- tissue
- human lymphatic
- Prior art date
Links
- 206010061598 Immunodeficiency Diseases 0.000 title abstract 3
- 210000003563 lymphoid tissue Anatomy 0.000 title abstract 3
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 2
- 238000010367 cloning Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000003306 harvesting Methods 0.000 abstract 1
- 210000000987 immune system Anatomy 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Environmental Sciences (AREA)
- Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biodiversity & Conservation Biology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51874890A | 1990-05-03 | 1990-05-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0481058T3 true DK0481058T3 (da) | 1996-12-02 |
Family
ID=24065324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91909374.0T DK0481058T3 (da) | 1990-05-03 | 1991-04-29 | Humant, lymfatisk væv i en immunokompromitteret vært |
Country Status (11)
Country | Link |
---|---|
US (1) | US5411749A (fr) |
EP (1) | EP0481058B1 (fr) |
JP (1) | JPH04507109A (fr) |
AT (1) | ATE140480T1 (fr) |
AU (1) | AU637914B2 (fr) |
CA (1) | CA2063408A1 (fr) |
DE (1) | DE69120890T2 (fr) |
DK (1) | DK0481058T3 (fr) |
ES (1) | ES2090332T3 (fr) |
GR (1) | GR3021382T3 (fr) |
WO (1) | WO1991016910A1 (fr) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5849288A (en) * | 1990-01-15 | 1998-12-15 | Yeda Research And Development Co. Ltd. | Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells |
US5652373A (en) * | 1990-01-15 | 1997-07-29 | Yeda Research And Development Co. Ltd. | Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems |
DK9091D0 (da) * | 1991-01-18 | 1991-01-18 | Novo Nordisk As | Fremgangsmaade til fremstilling af antistoffer |
US5858328A (en) * | 1991-06-04 | 1999-01-12 | Yeda Research And Development Co. Ltd. | Animal model for hepatitis virus infection |
US5804160A (en) * | 1991-06-04 | 1998-09-08 | Yeda Research And Development Co. Ltd | Animal model for hepatitis virus infection |
US5849987A (en) * | 1992-06-02 | 1998-12-15 | Yeda Research And Development Co. Ltd. | Animal model for hepatitis virus infection |
DE69229254T2 (de) * | 1991-10-30 | 1999-09-23 | Idemitsu Kosan Co | Verfahren zur Herstellung von menschlichen Lymphozyten und menschlichen Antikörpern; und so hergestellte Antikörper |
US5866757A (en) * | 1992-06-02 | 1999-02-02 | Yeda Research And Development Co. Ltd. | Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems |
JP2801085B2 (ja) * | 1992-09-11 | 1998-09-21 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | ヒト細胞を植えた気道上の異種移植片を有する非ヒト動物 |
CA2103693A1 (fr) * | 1993-08-06 | 1995-02-07 | Steven Gallinger | Modele animal du systeme immunitaire humain |
US5645982A (en) * | 1993-08-19 | 1997-07-08 | Systemix, Inc. | Method for screening potential therapeutically effective antiviral agents |
US5516977A (en) * | 1993-12-17 | 1996-05-14 | Systemix, Inc. | Xenogeneic tissue implant in ear pinna |
US6455756B1 (en) * | 1994-08-12 | 2002-09-24 | Novartis Ag | Long term xenogeneic myeloid and lymphoid cell production in chimeric immunocompromised mice |
EP0792294A1 (fr) * | 1994-11-16 | 1997-09-03 | Baxter International Inc. | Anticorps humains pour les peptides recepteurs de lymphocytes t et leur methode de preparation |
US5811524A (en) | 1995-06-07 | 1998-09-22 | Idec Pharmaceuticals Corporation | Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
US20020182730A1 (en) * | 1995-07-26 | 2002-12-05 | Micheal L. Gruenberg | Autologous immune cell therapy: cell compositions, methods and applications to treatment of human disease |
US5986170A (en) * | 1995-11-13 | 1999-11-16 | Corixa Corporation | Murine model for human carcinoma |
JP4312265B2 (ja) * | 1997-04-09 | 2009-08-12 | ラング−ジ チャン | ワクチン評価のための動物モデル |
DE60142614D1 (de) * | 2000-01-27 | 2010-09-02 | Medimmune Inc | Inität |
JP2003525061A (ja) | 2000-03-01 | 2003-08-26 | メディミューン,インコーポレイテッド | 高効力組換え抗体およびその産生法 |
US6855493B2 (en) | 2000-11-28 | 2005-02-15 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
US7179900B2 (en) * | 2000-11-28 | 2007-02-20 | Medimmune, Inc. | Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment |
FR2821947B1 (fr) * | 2001-03-12 | 2003-05-16 | Canon Kk | Procede et dispositif de validation de parametres definissant une image |
US20030134341A1 (en) * | 2001-09-19 | 2003-07-17 | Medcell Biologics, Llc. | Th1 cell adoptive immunotherapy |
US20030134415A1 (en) * | 2001-09-19 | 2003-07-17 | Gruenberg Micheal L. | Th1 cell adoptive immunotherapy |
US20030175272A1 (en) * | 2002-03-07 | 2003-09-18 | Medcell Biologics, Inc. | Re-activated T-cells for adoptive immunotherapy |
US7132100B2 (en) | 2002-06-14 | 2006-11-07 | Medimmune, Inc. | Stabilized liquid anti-RSV antibody formulations |
EP1635763B1 (fr) | 2003-06-09 | 2012-08-08 | Alnylam Pharmaceuticals Inc. | Procede de traitement de maladie neurodegenerative |
CA2585891A1 (fr) * | 2004-10-29 | 2006-05-11 | Medimmune, Inc. | Methodes de prevention et de traitement des infections a rsv et des etats pathologiques associes |
EP1997830A1 (fr) * | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | Molécules à liaison spécifiques RSV et leur moyen de fabrication |
US20090291073A1 (en) * | 2008-05-20 | 2009-11-26 | Ward Keith W | Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same |
US8349325B2 (en) | 2008-12-23 | 2013-01-08 | Abbott Laboratories | Soluble FMS-like tyrosine kinase-1 (sFLT-1) antibody and related composition, kit, methods of using, and materials and method for making |
US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
EP3056082B1 (fr) | 2009-10-06 | 2018-09-05 | Regeneron Pharmaceuticals, Inc. | Souris génétiquement modifiées et greffe |
US20110229921A1 (en) * | 2010-03-18 | 2011-09-22 | Abbott Laboratories | METHODS OF ASSAYING URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (uNGAL) IN THE PROGNOSIS OF CADAVERIC KIDNEY TRANSPLANT FUNCTION IN A PATIENT, INCLUDING A PATIENT DIAGNOSED WITH DELAYED GRAFT FUNCTION (DGF), A METHOD OF ASSAYING uNGAL IN THE ASSESSMENT OF RISK OF DGF IN A PATIENT DIAGNOSED WITH EARLY GRAFT FUNCTION (EGF), AND RELATED KITS |
WO2011163558A1 (fr) | 2010-06-25 | 2011-12-29 | Abbott Laboratories | Matériaux et procédés pour le dosage d'anticorps anti-virus de l'hépatite c (hvc) |
US20120115244A1 (en) | 2010-11-09 | 2012-05-10 | Abbott Laboratories | Materials and methods for immunoassay of pterins |
MY162984A (en) | 2011-02-15 | 2017-07-31 | Regeneron Pharma | Humanized m-csf mice |
US8993248B2 (en) | 2011-12-31 | 2015-03-31 | Abbott Laboratories | Truncated human vitamin D binding protein and mutation and fusion thereof and related materials and methods of use |
SG10201701759VA (en) | 2012-09-07 | 2017-04-27 | Univ Yale | Genetically modified non-human animals and methods of use thereof |
SG10201707449TA (en) | 2012-11-05 | 2017-10-30 | Regeneron Pharma | Genetically modified non-human animals and methods of use thereof |
EP3482629B1 (fr) | 2014-05-19 | 2020-11-25 | Regeneron Pharmaceuticals, Inc. | Animaux non humains génétiquement modifiés exprimant l'epo humaine |
RU2730599C2 (ru) | 2015-04-13 | 2020-08-24 | Ридженерон Фармасьютикалз, Инк. | Гуманизированные мыши с нокином sirpa-il15 и способы их использования |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3853201T2 (de) * | 1987-12-23 | 1995-09-14 | Univ Leland Stanford Junior | Schimäre immunkompromittierende Säugetiere und ihre Verwendung. |
JP2981486B2 (ja) * | 1988-06-14 | 1999-11-22 | メディカル・バイオロジー・インスティチュート | 哺乳動物の免疫系研究方法 |
DE69131331T2 (de) * | 1990-01-15 | 2000-03-02 | Yeda Res & Dev | Dauerhafte Verpflanzung und Entwicklung menschlicher hämatopoietischer Zellinien bei normalen Säugetieren |
WO1991018615A1 (fr) * | 1990-05-25 | 1991-12-12 | Systemix, Inc. | Globules de sang peripherique humain chez un hote presentant un deficit immunitaire |
JPH04252128A (ja) * | 1990-08-03 | 1992-09-08 | Systemix Inc | 免疫化された宿主における変性された異種移植器官系 |
-
1991
- 1991-04-29 EP EP91909374A patent/EP0481058B1/fr not_active Expired - Lifetime
- 1991-04-29 JP JP3509019A patent/JPH04507109A/ja active Pending
- 1991-04-29 DE DE69120890T patent/DE69120890T2/de not_active Expired - Fee Related
- 1991-04-29 AT AT91909374T patent/ATE140480T1/de active
- 1991-04-29 AU AU78583/91A patent/AU637914B2/en not_active Ceased
- 1991-04-29 WO PCT/US1991/002938 patent/WO1991016910A1/fr active IP Right Grant
- 1991-04-29 DK DK91909374.0T patent/DK0481058T3/da active
- 1991-04-29 CA CA002063408A patent/CA2063408A1/fr not_active Abandoned
- 1991-04-29 ES ES91909374T patent/ES2090332T3/es not_active Expired - Lifetime
-
1992
- 1992-12-23 US US07/996,831 patent/US5411749A/en not_active Expired - Fee Related
-
1996
- 1996-10-16 GR GR960402755T patent/GR3021382T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0481058A1 (fr) | 1992-04-22 |
DE69120890T2 (de) | 1997-02-20 |
EP0481058A4 (en) | 1993-07-14 |
AU637914B2 (en) | 1993-06-10 |
ATE140480T1 (de) | 1996-08-15 |
ES2090332T3 (es) | 1996-10-16 |
WO1991016910A1 (fr) | 1991-11-14 |
CA2063408A1 (fr) | 1991-11-04 |
JPH04507109A (ja) | 1992-12-10 |
GR3021382T3 (en) | 1997-01-31 |
EP0481058B1 (fr) | 1996-07-17 |
US5411749A (en) | 1995-05-02 |
DE69120890D1 (de) | 1996-08-22 |
AU7858391A (en) | 1991-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0481058T3 (da) | Humant, lymfatisk væv i en immunokompromitteret vært | |
ATE211767T1 (de) | Dämpfung eines immundominanten epitops eines antigens zur verwendung für pflanzen, tierische und menschliche impstoffe und immuntherapien | |
DE68924162T2 (de) | Stressproteine und verwendungen dafür. | |
DE69128476T2 (de) | Adoptive immuntherapie mit interleukin-7 | |
DE3853854T2 (de) | Vakzin gegen Neisseria meningitidis Gruppe-B, Gammaglobulin und Transferfaktor. | |
ATE195875T1 (de) | Spezifische modulationen des immunsystems | |
MX9705349A (es) | Anticuerpo monoclonal 1a7 y su uso para el tratamiento de melanona y carcinoma de celulas pequeñas. | |
DE69233012T2 (de) | Mit staphylococcus epidermidis assoziierte oberflächenantigene des typs i | |
EP0570583A4 (fr) | Agent modifiant l'etat des cheveux et produit de soin capilaire contenant chacun un anticorps antikeratinisation, et production dudit anticorps antikeratinisation. | |
DE3789082T2 (de) | Expression eines tumorspezifischen Antigens eines rekombinanten Virusvektors sowie dessen Anwendung zur versorgenden oder heilenden Behandlung des entsprechenden Tumors. | |
DE69022980T2 (de) | Gesteigerte erzeugung von proteinen in tieren. | |
ATE273022T1 (de) | Verfahren zur verstärkung zellularer immunantworten | |
DE68920672T2 (de) | Gerät zur Ableitung des Herzzeitvolumens mittels Thermodilution ohne Einspritzung. | |
ATE130194T1 (de) | Subkutane verabreichung des humanen choriongonadotropins. | |
MX9101012A (es) | Metodo para reducir la tintura del cuero cabelludo | |
ES2109954T3 (es) | Estimulacion del crecimiento con anticuerpos antiidiotipicos cultivados contra un anticuerpo a un polipeptido potenciador del crecimiento. | |
DK0542895T3 (da) | Krydsreaktiv influenza A immunisering | |
SE8101728L (sv) | Transforestring vid amider | |
GB867920A (en) | Process for the cooking of animal tissue | |
ATE152916T1 (de) | Die verwendung von anti-helminth impfstoffen zur kontrolle von parasitären krankheiten, die mit einem verlust der natürlichen immunität assoziiert sind | |
GB1380554A (en) | Treatment of poultry | |
UA13003A (uk) | Засіб для стимулюваhhя hавчаhhя та пам'яті | |
FR1394309A (fr) | Méthode d'accroissement de la production des oeufs chez les poules pondeuses | |
FR1112761A (fr) | Procédé et dispositif en vue de la préparation d'eaux appropriées aux traitements curatifs et aux soins corporels | |
ES451111A2 (es) | Metodo de obtencion de antimeros y anticuerpos para diagnos-tico y tratamiento del cancer. |